Roth Capital Starts Inovio Pharmaceuticals (INO) at Buy, $2 Price Target
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.29 +1.57%
Rating Summary:
11 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
11 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Roth Capital initiates coverage on shares of Inovio Pharmaceuticals (NYSE: INO) with a Buy rating and $2 price target.
For more ratings news on Inovio Pharmaceuticals click here and for the rating history of Inovio Pharmaceuticals click here.
Shares of Inovio Pharmaceuticals closed at $0.69 yesterday.
For more ratings news on Inovio Pharmaceuticals click here and for the rating history of Inovio Pharmaceuticals click here.
Shares of Inovio Pharmaceuticals closed at $0.69 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy
- Needham Starts Red Violet (RDVT) at Buy, 'offers the leading Cloud identity intelligence platform in the market today'
- LifeSci Capital Starts BlossomHill Therapeutics (BLSM) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
